MedTrace Logo

Patient Reported Outcomes in Pulmonary Arterial Hypertension

NCT01792622 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-01-28

No results posted yet for this study

Summary

Develop a brief, new, patient reported outcome instrument that is valid for use in clinical practice and clinical trials.

Conditions

Interventions

OTHER

Interview

Patients will be interviewed to provide descriptive information about their experience as a treated patient with pulmonary arterial hypertension. The interviews will be given one time for approximately 1 hour.

OTHER

Questionnaire

Patients will be asked to provide subjective ratings of their experience on a questionnaire developed from the responses from Phase I. The questionnaire will be given one time for approximately 1 hour.

Sponsors & Collaborators

  • University of Chicago

    collaborator OTHER

  • Mayo Clinic

    collaborator OTHER

  • Vanderbilt University

    collaborator OTHER

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2013-09-30
Completion
2013-09-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01792622 on ClinicalTrials.gov